Taking it to the streets. Stockhouse.com: Taking it to the street
Stem Cell Therapeutics Corp.  SSS go to snapshot add to favorites
reply post non-threaded view
print report abuse
Gilead Sciences to Acquire YM Biosciences
Fusionpower1
2/8/2013 5:22:01 PM | No Recommendation | 250 reads  | Post #32150485
 

Gilead Sciences, Inc.  and YM BioSciences Inc. (nyse mkt:YMI)  announced today that the companies have signed a definitive agreement under which Gilead will acquire YM for U.S.$2.95 per share in cash. The transaction has received the unanimous approval of YM's Board of Directors, and values YM at approximately U.S.$510 million.

 

Board of Directors

David G.P. Allan, Chairman of the Board

 

 
 
reply post non-threaded view
add to favorites
 
Company Showcase
 
View Sectors
 
 
 
Today's Feature  
View Now
 
Pacific North West Capital Corp.
Pacific North West Capital Corp. (TSX: PFN; OTCQX: PAWEF; Frankfurt: P7J) is a mineral exploration company focused on the discovery, exploration and development of PGM and nickel-copper sulphide deposits in geologically prospective regions in North America, particularly Canada. The Company's key asset is its 100% owned River Valley PGM Project in the Sudbury region of northern Ontario. The River Valley Project is one of North America's most advanced primary PGM deposits...